This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Pierre Fabre Medicament, Université Paris-Sud 11. Active years: 2008-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Chatenay-Malabry, FR (2008 - 2010)
- Reims, FR (2012)
Company Filing History:
3 out of 5,383 
1 out of 269 
1 out of 43 Years Active: 2008-2012
Title: Fabienne Grellepois: Innovator in Anticancer and Antimalarial Therapies
Introduction
Fabienne Grellepois is a prominent inventor based in Chatenay-Malabry, France. She has made significant contributions to the fields of anticancer and antimalarial therapies. With a total of 3 patents, her work focuses on innovative derivatives of artemisinin.
Latest Patents
Her latest patents include "Dimeric derivatives of artemisinin and application in anticancer therapy." This invention relates to dimeric derivatives of 10-trifluoromethylated artemisinin, which are used in treating cancer. Another notable patent is "Derivatives of artemisinin, and their uses in the treatment of malaria," which introduces new artemisinin derivatives aimed at combating malaria.
Career Highlights
Fabienne has worked with esteemed organizations such as the Centre National de la Recherche Scientifique and Pierre Fabre Medicament. Her experience in these institutions has allowed her to advance her research and contribute to significant medical innovations.
Collaborations
Throughout her career, Fabienne has collaborated with notable colleagues, including Jean-Pierre Begue and Benoît Crousse. These partnerships have enriched her research and expanded the impact of her inventions.
Conclusion
Fabienne Grellepois is a trailblazer in the development of artemisinin derivatives for cancer and malaria treatment. Her innovative work continues to influence the medical field and offers hope for effective therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile